Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ras-related protein Rab-20 (RAB20) is a member of the Rab subfamily within the Ras superfamily of small GTPases. It plays a key role in the regulation of intracellular membrane trafficking, especially in the maturation and acidification of phagosomes and in endocytosis[4][3][1]. RAB20 is expressed in multiple cell types and is notably upregulated in response to immune stimuli such as interferon-gamma and hypoxia, participating in immune regulation by controlling endosome maturation in macrophages and mediating apoptosis under stress conditions, such as during cerebral ischemia/reperfusion injury and high glucose exposure[2][3][4]. Disruption or knockdown of RAB20 has shown protective effects against neuronal apoptosis in cerebral ischemia models, highlighting its potential as a therapeutic target for injury and inflammation, though no current drugs directly target it[2]. The protein is primarily found on endocytic vesicles, the Golgi apparatus, and phagocytic membranes[1][3][4]. Key roles include promoting homotypic fusion of early endosomes, regulating phagosome-lysosome fusion, and modulating cell death pathways in response to cellular stress or immune activation[2][3][4]. Diseases associated with RAB20 include infectious and inflammatory conditions, such as laryngeal tuberculosis, and experimental models point to relevance in cerebral ischemic injury and metabolic stress responses[2][4].
No known drugs directly targeting RAB20, but knockdown or inhibition of RAB20 shown to reduce apoptosis and tissue injury in preclinical models.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras-related protein Rab-20 (RAB20).